Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2016

Dec 16, 2016

29777_dirs_2016-12-16_302b67af-2925-435b-926c-fd9d9b6823b2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2016-12-13

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-12-13 Common shares without par value G 2040 Disposed 3109927 Direct
2016-12-13 Common shares without par value G 1020 Acquired 1020 Indirect
2016-12-13 Common shares without par value G 340 Acquired 9158 Indirect
2016-12-13 Common shares without par value G 340 Acquired 9172 Indirect
2016-12-13 Common shares without par value G 1020 Disposed 0 Indirect
2016-12-13 Common shares without par value G 340 Acquired 9498 Indirect
2016-12-13 Common shares without par value G 340 Acquired 9512 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 30094 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 13, 2016.

F2: The reporting person disclaims beneficial ownership of all securities held by his wife and sons.